• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday

    7/6/22 5:21:53 AM ET
    $AEG
    $AGE
    $AGEN
    $AGMH
    Life Insurance
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEG alert in real time by email

    Gainers

    • Enjoy Technology, Inc. (NASDAQ:ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
    • Rubicon Technology, Inc. (NASDAQ:RBCN) shares surged 66.1% to settle at $15.05 on Tuesday after the company announced that it entered into a definitive stock purchase and sale agreement with Janel Corporation.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares jumped 48.7% to close at $5.28 after jumping over 36% on Friday.
    • Nuwellis, Inc. (NASDAQ:NUWE) gained 48.5% to close at $0.90. Nuwellis recently said that first patient was enrolled in pivotal trial REVERSE-HF.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) surged 41.8% to close at $2.75. Lexicon Pharmaceuticals recently reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy.
    • ZW Data Action Technologies Inc. (NASDAQ:CNET) jumped 40.9% to close at $0.4779.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) jumped 40.1% to close at $3.60. Avadel Pharmaceuticals recently announced its steps to explore every available pathway to accelerate the FDA approval of its lead drug candidate, FT218, before June 2023.
    • AGM Group Holdings Inc. (NASDAQ:AGMH) gained 39.8% to close at $1.65.
    • Ra Medical Systems, Inc. (NASDAQ:RMED) shares climbed 39.2% to close at $0.4301 on Tuesday after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 38.7% to close at $10.50 after dropping 16% on Friday.
    • IsoPlexis Corporation (NASDAQ:ISO) rose 33.2% to close at $2.85.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) jumped 32.4% to close at $0.9794. Panbela recently announced publication of preclinical data titled: 'Expanded Potential of the Polyamine Analogue SBP-101 (Diethyl Dihydroxyhomospermine) as a Modulator of Polyamine Metabolism and Cancer Therapeutic.'
    • Cowen Inc. (NASDAQ:COWN) gained 28.7% to close at $30.93.
    • Four Seasons Education (Cayman) Inc. (NYSE:FEDU) surged 27.2% to close at $15.20.
    • Carvana Co. (NYSE:CVNA) jumped 26.1% to close at $27.58. Needham maintained Carvana with a Buy and lowered the price target from $80 to $31.
    • Talaris Therapeutics, Inc. (NASDAQ:TALS) rose 26.1% to close at $2.90. Morgan Stanley downgraded Talaris Therapeutics from Overweight to Equal-Weight and announced an $8 price target.
    • Local Bounti Corporation (NYSE:LOCL) jumped 25.1% to close at $4.04.
    • 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 24.8% to close at $10.34. One Medical was said to consider options after a takeover interest, Bloomberg reported.
    • Atreca, Inc. (NASDAQ:BCEL) jumped 24.6% to settle at $2.23.
    • Uxin Limited (NASDAQ:UXIN) climbed 24.3% to close at $0.5593. Uxin recently announced entry into definitive agreements for financing transaction of $100 million in replacement of the previously announced binding term sheet.
    • BitNile Holdings, Inc. (NYSE:NILE) gained 23.1% to close at $0.3420. BitNile Holdings’ Executive Chairman Milton C. Ault III acquired a total of 900,000 shares at an average price of $0.27.
    • Agenus Inc. (NASDAQ:AGEN) jumped 23% to settle at $2.41. Agenus recently announced expanded data from its Phase 1b study of botensilimab.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) jumped 22.7% to close at $1.03.
    • AgeX Therapeutics, Inc. (NYSE:AGE) gained 22.6% to close at $0.70. AgeX Therapeutics, during May, posted a Q1 loss of $0.07 per share.
    • Blue Star Foods Corp. (NASDAQ:BSFC) climbed 21% to close at $1.44.
    • Symbotic Inc. (NASDAQ:SYM) climbed 20.8% to close at $14.36. Raymond James initiated coverage on Symbotic with an Outperform rating and announced a price target of $18.
    • Midatech Pharma plc (NASDAQ:MTP) surged 20% to settle at $0.66.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 19.9% to close at $36.49.
    • BioAtla, Inc. (NASDAQ:BCAB) gained 19.7% to settle at $3.52.
    • Inhibrx, Inc. (NASDAQ:INBX) jumped 19% to close at $13.78. Inhibrx recently reported completion of Phase 1 combination dose escalation for INBRX-105.
    • OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) rose 18.9% to close at $2.20. OneConnect successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) gained 18.2% to close at $2.66. Cognition Therapeutics recently dosed first patient in the SHIMMER study of lead drug CT1812, an experimental, orally delivered small molecule therapeutic intended to address the underlying biology of dementia with Lewy bodies (DLB).
    • BioVie Inc. (NASDAQ:BIVI) gained 18.1% to close at $1.63.
    • bluebird bio, Inc. (NASDAQ:BLUE) rose 18% to close at $5.05.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) gained 17.8% to settle at $1.04.
    • Dyne Therapeutics, Inc. (NASDAQ:DYN) gained 17.2% to close at $8.44 after the company announced FDA clearance of its Investigational New Drug application for DYNE-251 for the treatment of Duchenne muscular dystrophy.
    • Tupperware Brands Corporation (NYSE:TUP) gained 16.4% to close at $7.80.
    • Precigen, Inc. (NASDAQ:PGEN) gained 14.9% to close at $1.62 after the company agreed to sell its subsidiary Trans Ova Genetics to URUS for $170 million in upfront cash.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 13.2% to close at $0.66.
    • Athenex, Inc. (NASDAQ:ATNX) surged 12.5% to settle at $0.4870.
    • Maris-Tech Ltd. (NASDAQ:MTEK) gained 12.1% to close at $1.30 on Tuesday after the company received a purchase order from SpaceIL for the development of a video recording, streaming and image processing solution for the Beresheet 2 Lunar Mission.
    • Offerpad Solutions Inc. (NYSE:OPAD) rose 11.7% to close at $2.48.
    • NewAge, Inc. (NASDAQ:NBEV) gained 11.6% to close at $0.2605. NewAge, last month, reported a review of strategic alternatives.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) rose 8.4% to close at $0.4315 after declining over 7% on Friday.
    • Tyme Technologies, Inc. (NASDAQ:TYME) gained 8.1% to close at $0.2921. Syros Pharmaceuticals has agreed to acquire TYME Technologies, including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million.
    • Alphabet Inc. (NASDAQ:GOOGL) jumped 4.2% to close at $2,265.26. Barclays maintained Alphabet with an Overweight and lowered the price target from $3200 to $3000.
    • Tesla, Inc. (NASDAQ:TSLA) gained 2.6% to settle at $699.20. JP Morgan lowered price target for Tesla from $395 to $385.

     


    Losers

    • Omeros Corporation (NASDAQ:OMER) dipped 33.4% to close at $3.09.
    • PARTS iD, Inc. (NYSE:ID) fell 24.8% to close at $1.12.
    • RiceBran Technologies (NASDAQ:RIBT) dipped 24.4% to close at $0.4285.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) fell 23.1% to close at $4.75. Staffing 360 Solutions reported a $4 million private placement priced at-the-market under Nasdaq rules.
    • Kalera Public Limited Company (NASDAQ:KAL) shares dipped 22.4% to close at $2.80 on Tuesday after tumbling 39% on Friday.
    • Phoenix Motor Inc. (NASDAQ:PEV) dropped 22.4% to close at $3.61.
    • Vivakor, Inc. (NASDAQ:VIVK) declined 21.2% to close at $1.60.
    • Fast Radius, Inc. (NASDAQ:FSRD) fell 20.9% to close at $46.11 after jumping 41% on Friday. Fast Radius, last month, appointed Pat McCusker as President, Interim CFO and John Nanry as COO.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 20.1% to close at $0.8311.
    • Volcon, Inc. (NASDAQ:VLCN) dipped 20% to close at $1.36. Volcon recently launched an all-electric Volcon Stag utility vehicle.
    • Pintec Technology Holdings Limited (NASDAQ:PT) dropped 18.8% to settle at $1.12.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) fell 18.6% to close at $0.57.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) dipped 16.6% to settle at $1.41.
    • Harte Hanks, Inc. (NASDAQ:HHS) fell 16.1% to close at $10.55. Harte Hanks recently announced an agreement to repurchase preferred shares from Wipro.
    • Nine Energy Service, Inc. (NYSE:NINE) declined 15.5% to settle at $2.23.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) dropped 15.4% to close at $2.41.
    • Miromatrix Medical Inc. (NASDAQ:MIRO) declined 15.2% to close at $2.80. Miromatrix applauded the FDA for its continued commitment to the field of organ transplant.
    • Nemaura Medical Inc. (NASDAQ:NMRD) dipped 14.4% to close at $2.20. Nemaura Medical reported its Q4 earnings results on Thursday, June 30, 2022.
    • Mega Matrix Corp. (NYSE:MTMT) declined 12.3% to close at $1.50.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 11.5% to close at $0.5425.
    • Cryptyde, Inc. (NASDAQ:TYDE) shares fell 10.9% to close at $1.24 after dipping around 32% on Friday.
    • Aegon N.V. (NYSE:AEG) fell 9.4% to close at $4.07.
    • Austin Gold Corp. (NYSE:AUST) shares fell 9.3% to close at $1.65.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) fell 8.8% to close at $0.1934. Allena Pharmaceuticals announced rescheduling of special meeting to approve reverse stock split.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) dropped 8.4% to settle at $5.60.
    • WPP plc (NYSE:WPP) shares fell 8.4% to close at $46.11. WPP recently announced plans to acquire Bower House Digital.
    • Halliburton Company (NYSE:HAL) dropped 8.1% to close at $28.89.
    • Usio, Inc. (NASDAQ:USIO) fell 6.3% to close at $2.25. Usio’s CEO provided a business update today.
    • Augmedix, Inc. (NASDAQ:AUGX) fell 6.1% to close at $1.86.
    Get the next $AEG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEG
    $AGE
    $AGEN
    $AGMH

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    1/23/2026$333.00 → $346.00Buy
    Stifel
    BioAtla Inc.
    $BCAB
    1/13/2026$4.00Buy
    Rodman & Renshaw
    Alphabet Inc.
    $GOOGL
    1/12/2026$268.00 → $350.00Equal Weight
    Wells Fargo
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    WPP plc
    $WPP
    1/12/2026Neutral
    Citigroup
    More analyst ratings

    $AEG
    $AGE
    $AGEN
    $AGMH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Revelation Biosciences Inc.

    SCHEDULE 13G/A - REVELATION BIOSCIENCES, INC. (0001810560) (Subject)

    2/17/26 9:37:07 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Alphabet Inc.

    SCHEDULE 13G/A - Alphabet Inc. (0001652044) (Subject)

    2/17/26 8:39:02 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    SEC Form 144 filed by Alphabet Inc.

    144 - Alphabet Inc. (0001652044) (Subject)

    2/17/26 4:36:37 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AEG
    $AGE
    $AGEN
    $AGMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/4/26 4:25:05 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner National Services, Inc bought $411,562 worth of shares (198,232 units at $2.08) and sold $44,498 worth of shares (31,897 units at $1.40), increasing direct ownership by 6% to 2,813,172 units (SEC Form 4)

    4 - Usio, Inc. (0001088034) (Issuer)

    12/29/25 6:08:22 AM ET
    $USIO
    Investment Bankers/Brokers/Service
    Finance

    Director Langer Dennis bought $128,640 worth of ADSs (15,152 units at $8.49), increasing direct ownership by 1,515,200% to 15,153 units (SEC Form 4)

    4 - Quoin Pharmaceuticals, Ltd. (0001671502) (Issuer)

    10/15/25 5:15:20 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    $AEG
    $AGE
    $AGEN
    $AGMH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEG
    $AGE
    $AGEN
    $AGMH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AGMH Announces Strategic Trifecta: RWA Tokenization, Mass Production of Kraken All-Flash AI Servers, and MusicDog.ai Partnership to Build Full-Stack AI + Web3 Ecosystem

    NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (NASDAQ:AGMH) ("AGMH" or the "Company"), an integrated technology company focused on high-performance hardware and computing equipment assembly and sales, today officially announced its comprehensive strategic layout involving Real World Asset (RWA) tokenization, the mass production of Kraken All-Flash AI Servers, and a strategic partnership with MusicDog.ai. The Company aims to utilize a "Cash Flow + Hardware Infrastructure + AI Smart Applications" trinity model to create a powerful flywheel effect, accelerating its transformation from an AI hardware supplier to a full-stack AI + Web3 ecosystem platform. I. RWA Financin

    2/18/26 7:50:00 AM ET
    $AGMH
    EDP Services
    Technology

    Offerpad Appoints Tela Gallagher Mathias to Board of Directors

    Offerpad Solutions Inc. (NYSE:OPAD) today announced appointment of Tela Gallagher Mathias to its Board of Directors. Mathias will serve on the company's Audit Committee and Compensation Committee, further strengthening governance oversight as Offerpad accelerates its AI strategy and scales its multi-solution real estate operating model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217840736/en/Tela Gallagher Mathias, Offerpad Board Member Mathias brings more than 25 years of experience designing and deploying enterprise technology platforms across mortgage, housing finance, and regulatory environments, with deep expertise i

    2/17/26 9:03:00 AM ET
    $OPAD
    Real Estate
    Finance

    Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

    — OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — Omeros Corporation (NASDAQ:OMER) today announced the successful completion of its initial study in nonhuman primates evaluating the efficacy and safety of its OncotoX-AML cancer therapeutic platform. Omeros' OncotoX-AML therapeutic is first targeting acute myeloid leukemia (AML), an aggressive and highly fatal bone marrow and blood cancer. The effectiveness of current AML treatments, such as chemotherapeutics and antibody-drug conjugates, are limited by substantial side effects. Administration of only one course of OncotoX-AML treatment to immunocompetent primates demonstrated the desired

    2/17/26 8:45:00 AM ET
    $OMER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEG
    $AGE
    $AGEN
    $AGMH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $360.00 from $330.00 previously

    1/26/26 10:43:23 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AEG
    $AGE
    $AGEN
    $AGMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hennessy John L. sold $184,037 worth of shares (600 units at $306.73) (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/17/26 8:24:00 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Johnson Albert increased direct ownership by 245% to 358,837 units (SEC Form 5)

    5 - Vivakor, Inc. (0001450704) (Issuer)

    2/17/26 6:43:05 PM ET
    $VIVK
    Environmental Services
    Utilities

    SEC Form 5 filed by Johnson Albert

    5 - Vivakor, Inc. (0001450704) (Issuer)

    2/17/26 6:42:40 PM ET
    $VIVK
    Environmental Services
    Utilities

    $AEG
    $AGE
    $AGEN
    $AGMH
    Financials

    Live finance-specific insights

    View All

    Local Bounti Receives Continued Listing Standard Notice from NYSE

    HAMILTON, Mont., Feb. 11, 2026 /PRNewswire/ -- Local Bounti Corporation (NYSE:LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company, today announced that on February 5, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") that it is not in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual (the "Minimum Market Capitalization Standard") due to the fact that the Company's average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders' equity was less than $50 million.

    2/11/26 4:05:00 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    Vivakor Signs Letter of Intent to Sell its Midstream Business in Oklahoma STACK Play for $36 Million to Olenox Industries

    Dallas, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTC:VIVK) ("Vivakor" or the "Company"), an integrated provider of energy transportation, storage, reuse, and remediation service, today announced that it has executed a non-binding Letter of Intent to sell its midstream business and transportation assets of CPE Gathering MidCon, LLC ("CPE Gathering") to Olenox Industries, Inc. (NASDAQ:OLOX) for approximately $36 million. Vivakor is the owner and operator of the Omega pipeline system, an integrated crude-oil gathering, transportation, terminaling and pipeline connection platform serving the Oklahoma STACK play. The transaction, valued at approximately $36 million, will be paid i

    2/2/26 8:30:00 AM ET
    $OLOX
    $VIVK
    RETAIL: Building Materials
    Consumer Discretionary
    Environmental Services
    Utilities

    Olenox Industries Signs Letter of Intent to Acquire Vivakor's Midstream Business in Oklahoma STACK Play

    CONROE, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- via IBN -- Olenox Industries Inc. (NASDAQ:OLOX) ("Olenox Industries" or the "Company"), today announced that it has executed a non-binding Letter of Intent to acquire the midstream business and transportation assets of CPE Gathering MidCon, LLC ("CPE Gathering") from Vivakor, Inc. (OTC:VIVK), owner and operator of the Omega pipeline system, an integrated crude-oil gathering, transportation, terminaling and pipeline connection platform serving the Oklahoma STACK play.   The transaction, valued at approximately $36 million, will be paid in a combination of cash, promissory note, common and preferred stock, and is based on $4.56 million in ann

    1/29/26 8:30:00 AM ET
    $OLOX
    $VIVK
    RETAIL: Building Materials
    Consumer Discretionary
    Environmental Services
    Utilities

    $AEG
    $AGE
    $AGEN
    $AGMH
    Leadership Updates

    Live Leadership Updates

    View All

    Offerpad Appoints Tela Gallagher Mathias to Board of Directors

    Offerpad Solutions Inc. (NYSE:OPAD) today announced appointment of Tela Gallagher Mathias to its Board of Directors. Mathias will serve on the company's Audit Committee and Compensation Committee, further strengthening governance oversight as Offerpad accelerates its AI strategy and scales its multi-solution real estate operating model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217840736/en/Tela Gallagher Mathias, Offerpad Board Member Mathias brings more than 25 years of experience designing and deploying enterprise technology platforms across mortgage, housing finance, and regulatory environments, with deep expertise i

    2/17/26 9:03:00 AM ET
    $OPAD
    Real Estate
    Finance

    Offerpad Appoints Dr. Jai Singh as Chief Pricing and Analytics Officer to Lead AI-Driven Pricing and Portfolio Strategy

    Offerpad Solutions Inc. (NYSE:OPAD) today announced the appointment of Dr. Jai Singh as Chief Pricing and Analytics Officer, reflecting an expanded mandate to accelerate the company's AI-driven pricing, portfolio management, and marketing optimization initiatives as Offerpad continues to scale its multi-solution real estate platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203766199/en/Dr. Jai Singh - Offerpad Chief Pricing and Analytics Officer Dr. Singh has extensive financial and analytical leadership experience, with a background spanning senior roles across investment management and global financial services organ

    2/3/26 9:05:00 AM ET
    $OPAD
    Real Estate
    Finance

    Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors

    BOSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors, effective January 1, 2026. Dr. Incerti is a highly accomplished executive with a strong background in medicine and over 35 years of strategic experience in the biopharmaceutical industry. "Carlo's appointment comes at a pivotal moment for Sparrow as we are looking ahead to pivotal trials of clofutriben for type 2 diabetes and seeking to expand development into other cardiometabolic indications," said Robert Jacks, Sparrow President and Chief Executive Officer. "Carlo is respected globally for

    2/2/26 8:30:00 AM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEG
    $AGE
    $AGEN
    $AGMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    12/13/24 11:34:57 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care